Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- ChecktodayChange DetectedRevision history updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry (Revision: v3.4.2) was added and the previous revision (Revision: v3.4.1) was removed from the record history, updating the version list for the study.SummaryDifference0.1%

- Check36 days agoChange DetectedThe record history shows the addition of a new revision entry: Revision v3.4.1, and the deletion of Revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedUI changes include a glossary toggle, and color-coded highlights with a new revision label (v3.4.0); no substantive study data or core content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check58 days agoChange DetectedThe Record History added a new revision entry (v3.3.4) and removed the previous revision (v3.3.3).SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now includes a new revision entry 'Revision: v3.3.3' for NCT05292898. The footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.